Tomohiro Yamauchi, Ph.D. Executive Director, Global Head of Scouting & Transaction Oncology, Business Development, Astellas Pharma Dr. Yamauchi has worked at Astellas for 16+ years in various roles with increasing responsibility in Business Development, R&D, Corporate and Portfolio Strategy to lead multiple business transactions (including M&A, in-/out-licensing, new company creation, asset sale, clinical combo trial collaboration and CDx collaboration), pipeline prioritization and portfolio management. He has more than 10 years’ experience of research in oncology and published several scientific papers in well-recognized journals, including EMBO J. and Clinical Cancer Res. Prior to joining Astellas, he served as a research associate in RIKEN, Japan, and obtained a Ph.D. in Medicine from Tsukuba University and also had the clinical pharmacist license in Japan.